CRISPR Therapeutics AG (CRSP) Up 20.5% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/06/23
Wall Street Analysts Think CRISPR Therapeutics AG (CRSP) Could Surge 27.15%: Read This Before Placing a BetZacks Investment Research • 12/06/23
CRISPR Therapeutics Announces Updates to Immuno-Oncology Pipeline and Expansion into Autoimmune DiseaseGlobeNewsWire • 12/04/23
Here's Why CRISPR Therapeutics AG (CRSP) is a Great Momentum Stock to BuyZacks Investment Research • 11/29/23
What's Next For Gene-Editing Darling Crispr After Its 'Historic' First-Ever Approval?Investors Business Daily • 11/29/23
5 Biotech Stocks Likely to Thrive as Industry Prospects Look BrightZacks Investment Research • 11/22/23
Wall Street Analysts Believe CRISPR Therapeutics AG (CRSP) Could Rally 33.75%: Here's is How to TradeZacks Investment Research • 11/20/23
Could Investing $10,000 In CRISPR Therapeutics Stock Make You a Millionaire?The Motley Fool • 11/19/23